Search
for

    Research 10 of 1000+

    1. Alteration of Skin Properties with Autologous Dermal Fibroblasts International Journal of Molecular Sciences · 2014 · 67 citations
    2. 707 Hypoxia induced Multipotent Stem Cell-Secreted Proteins Induce Hair Growth in a Phase 1a/2b trial in Male Pattern Baldness Journal of Investigative Dermatology · 2021
    3. The Hair Growth-Promoting Effect of<i>Rumex japonicus</i>Houtt. Extract Evidence-based Complementary and Alternative Medicine · 2016 · 8 citations
    4. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study British Journal of Dermatology · 2018 · 11 citations
    5. Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial Journal of the American Academy of Dermatology · 2021 · 20 citations
    6. La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME) · 2023
    7. Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial medRxiv · 2026
    8. A phase 2a trial of brepocitinib for cicatricial alopecia Journal of the American Academy of Dermatology · 2024 · 17 citations
    9. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study Journal of Dermatological Treatment · 2026
    10. 609 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates female telogen effluvium: Randomized, double-blinded, placebo-controlled clinical trial Journal of Investigative Dermatology · 2019
    All research results →

    Learn 1 of 27

    1. PP405 mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
    All learn results →

    Community

    — no results

    Try a deeper search in community →